PERSPECTA

News from every angle

← Back to headlines

FDA Schedules Meeting to Reassess Peptide Restrictions

The U.S. Food and Drug Administration is moving forward with plans to reassess restrictions on certain popular peptides, including scheduling an Advisory Committee meeting to decide on potentially lifting them. This development has led to a jump in Hims & Hers stock.

15 Apr, 21:39 — 15 Apr, 21:39
PostShare

Sources

Showing 1 of 2 sources
marketwatchMostly Factual2h ago

Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides

Hims & Hers Health’s plan to enter the business of selling peptides is looking a lot more realistic.

By Jaimy Lee

Read full article →

Coverage Timeline

First report: seeking-alpha · 15 Apr, 17:42Full coverage: 2 · 4hWindow: 4h
Left-leaningCenterRight-leaning
seeking-alpha15 Apr, 17:42First to report

FDA sets up AdCom meeting to decide on lifting restrictions on certain peptides

4h later
marketwatch15 Apr, 21:39Latest update

Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides

Related Stories

University of Lagos Launches Precision Healthcare Initiative Against Misdiagnosis

19m ago

Indian Drag Artist Coco Flash Celebrates Heritage and Fights for Future

33m ago

Children starting school lack basic skills, including toilet training

35m ago

Report calls for 1,400 more educational psychologists in England

39m ago